XenoPort, Inc.
Pharmaceutical Manufacturing
113 employees
- Employees
- 113
- Contacts
- 1
- Emails
- 1
- Phones
- 1
XenoPort, Inc. Overview
- Phone Number
- Available in AeroLeads
- Website
- xenoport.com
- Industry
- Pharmaceutical Manufacturing
- Employees
- 113
- Founded
- 1999
- Funding
- 20.0M
- Company Email
- Available in AeroLeads
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation Manufacturing
Keywords
About XenoPort, Inc.
XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. Horizant® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in the United States by XenoPort. Regnite® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in Japan by Astellas Pharma Inc. XenoPort holds all other world-wide rights to gabapentin enacarbil. XenoPort's pipeline of product candidates includes potential treatments for patients with Parkinson's disease, relapsing-remitting multiple sclerosis and psoriasis.
XenoPort, Inc. Contact Details
- People in AeroLeads
- 2
- With contact data
- 1
- Email contacts
- 1
- 50.0% coverage
- Phone contacts
- 1
- 50.0% coverage
XenoPort, Inc. Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Rajini Rajanna | Cupertino, California, United States |
Email
Phone
|
|
| David R. Savello, Ph.d. | Santa Clara, California, United States |
View
|
Employees by Management Level
Individual contributor
12 profiles
Director
10 profiles
Manager
10 profiles
Executive
2 profiles
Senior / Lead
1 profile
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| Executive | 7 | 7 | 2 |
| General | 5 | 5 | 2 |
| Sales | 4 | 3 | 1 |
| IT | 2 | 2 | 0 |
| Healthcare | 2 | 2 | 0 |
| Operations | 1 | 1 | 0 |
XenoPort, Inc. Tech Stack
Cloud / infrastructure
1 profile
Engineering
1 profile
Compare Similar Companies to XenoPort, Inc.
Bristol Myers Squibb
Pharmaceutical Manufacturing
Amgen
Biotechnology Research
Azurity Pharmaceuticals
Pharmaceutical Manufacturing
Corcept Therapeutics
Biotechnology Research
DCVC
Venture Capital And Private Equity Principals
Talphera, Inc.
Pharmaceutical Manufacturing
IFM Therapeutics
Biotechnology Research
Optivia Biotechnology
Pharmaceutical Manufacturing
InBios International
Medical Equipment Manufacturing
Nektar Therapeutics
Biotechnology